Legal & Attorney Advice GLP-1 agonists like Ozempic may reduce cardiovascular events by 20% 5 hours ago 0 GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) are rewriting the heart-health conversation. A landmark cardiovascular outcomes trial found... Read More Read more about GLP-1 agonists like Ozempic may reduce cardiovascular events by 20%
